These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of glucocorticoids on Thrombospondin-1, Osteocalcin and the Thrombospondin-1:Osteocalcin ratio in humans. Cesana-Nigro N; Keshvari S; Barclay JL; Sorbello J; Upham JW; Benham H; Anderson ST; Steiger N; Prins JB; Inder WJ Clin Endocrinol (Oxf); 2019 Dec; 91(6):728-736. PubMed ID: 31612515 [TBL] [Abstract][Full Text] [Related]
3. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency. Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163 [TBL] [Abstract][Full Text] [Related]
7. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M; Elias LL; Elias PC; Moreira AC Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925 [TBL] [Abstract][Full Text] [Related]
8. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. Wise JK; Hendler R; Felig P J Clin Invest; 1973 Nov; 52(11):2774-82. PubMed ID: 4748510 [TBL] [Abstract][Full Text] [Related]
9. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers. Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285 [TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. Yanovski JA; Cutler GB; Chrousos GP; Nieman LK JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630 [TBL] [Abstract][Full Text] [Related]
12. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test. Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812 [TBL] [Abstract][Full Text] [Related]
13. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas. Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273 [TBL] [Abstract][Full Text] [Related]
14. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666 [TBL] [Abstract][Full Text] [Related]
15. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease. Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160 [TBL] [Abstract][Full Text] [Related]
16. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome. Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595 [TBL] [Abstract][Full Text] [Related]
17. Paradoxical ACTH response to glucocorticoids in Cushing's disease. Fehm HL; Voight KH; Lang RE; Beinert KE; Kummer GW; Pfeiffer EF N Engl J Med; 1977 Oct; 297(17):904-7. PubMed ID: 198654 [TBL] [Abstract][Full Text] [Related]
18. Perioperative glucocorticoid prescribing habits in patients with inflammatory bowel disease: a call for standardization. Lamore RF; Hechenbleikner EM; Ha C; Salvatori R; Harris LH; Marohn MR; Gearhart SL; Efron JE; Wick EC JAMA Surg; 2014 May; 149(5):459-66. PubMed ID: 24647868 [TBL] [Abstract][Full Text] [Related]
19. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689 [TBL] [Abstract][Full Text] [Related]
20. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial. Werumeus Buning J; van Faassen M; Brummelman P; Dullaart RP; van den Berg G; van der Klauw MM; Kerstens MN; Stegeman CA; Muller Kobold AC; Kema IP; Wolffenbuttel BH; van Beek AP J Clin Endocrinol Metab; 2016 Oct; 101(10):3691-3699. PubMed ID: 27490921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]